- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/16 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with acylated ring nitrogen atom
Patent holdings for IPC class C07D 211/16
Total number of patents in this class: 236
10-year publication summary
|
15
|
28
|
14
|
12
|
17
|
9
|
8
|
12
|
7
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Global Blood Therapeutics, Inc. | 165 |
5 |
| Sanofi | 4338 |
5 |
| VALO Health, Inc. | 196 |
5 |
| F. Hoffmann-La Roche AG | 7795 |
4 |
| Conopco, Inc. | 5137 |
4 |
| Boehringer Ingelheim International GmbH | 4491 |
4 |
| Genzyme Corporation | 1383 |
4 |
| Incyte Corporation | 1068 |
4 |
| Incyte Holdings Corporation | 610 |
4 |
| PFG Holding Corporation | 117 |
4 |
| Sagimet Biosciences Inc. | 29 |
4 |
| Excir Works Corp. | 31 |
4 |
| The Regents of the University of California | 20960 |
3 |
| California Institute of Technology | 4044 |
3 |
| Commissariat à l'énergie atomique et aux energies alternatives | 11137 |
3 |
| Indiana University Research and Technology Corporation | 780 |
3 |
| Modernatx, Inc. | 1278 |
3 |
| New York University | 1861 |
3 |
| Rutgers, The State University of New Jersey | 1996 |
3 |
| Lead Pharma Holding B.V. | 20 |
3 |
| Other owners | 161 |